Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment ...

SkyQuest Technology Consulting published a report, titled, Remote Patient Monitoring Market - Global Opportunity Analysis and Indust ...

Ketamine’s rapid antidepressant effects may involve the brain’s opioid system, offering insight into how it works and paving ...

50% compression of full target–disease–drug analysis workflows Rare disease landscape mapping shortened from 12 weeks to under 3 ...